These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent. Gahtan V; Wang XJ; Willis AI; Tuszynski GP; Sumpio BE Surgery; 1999 Aug; 126(2):203-7. PubMed ID: 10455885 [TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated. Seymour KA; Sadowitz B; Stein JJ; Lawler J; Maier KG; Gahtan V Am J Surg; 2011 Nov; 202(5):553-7. PubMed ID: 21906719 [TBL] [Abstract][Full Text] [Related]
12. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway. Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187 [TBL] [Abstract][Full Text] [Related]
13. Lovastatin increases nitric oxide synthesis in IL-1 beta-stimulated smooth muscle cells. Chen H; Xing Y; Liu R Chin Med J (Engl); 2001 Nov; 114(11):1123-7. PubMed ID: 11729502 [TBL] [Abstract][Full Text] [Related]
14. Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase. Johnson MD; Woodard A; Okediji EJ; Toms SA; Allen GS J Neurooncol; 2002 Jan; 56(2):133-42. PubMed ID: 11995814 [TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. Maier KG; Sadowitz B; Cullen S; Han X; Gahtan V Am J Surg; 2009 Nov; 198(5):664-9. PubMed ID: 19887196 [TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains. Lee T; Nesselroth SM; Olson ET; Esemuede N; Lawler J; Sumpio BE; Gahtan V J Cell Biochem; 2003 Jun; 89(3):500-6. PubMed ID: 12761883 [TBL] [Abstract][Full Text] [Related]
17. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling. Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195 [TBL] [Abstract][Full Text] [Related]
18. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells. Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972 [TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9. Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080 [TBL] [Abstract][Full Text] [Related]
20. Lovastatin induces apoptosis in malignant mesothelioma cells. Rubins JB; Greatens T; Kratzke RA; Tan AT; Polunovsky VA; Bitterman P Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1616-22. PubMed ID: 9603146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]